DFREX | IARRX | DFREX / IARRX | |
Total Expense Ratio | 0.18 | 1.63 | 11% |
Annual Report Gross Expense Ratio | 0.20 | 1.63 | 12% |
Fund Existence | 33 years | 21 years | - |
Gain YTD | 2.155 | -0.864 | -250% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.66B | 682M | 977% |
Annual Yield % from dividends | 2.51 | 1.66 | 151% |
Returns for 1 year | -3.91 | -8.50 | 46% |
Returns for 3 years | 26.72 | 6.84 | 391% |
Returns for 5 years | 27.70 | -1.58 | -1,758% |
Returns for 10 years | 62.83 | -29.19 | -215% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PPH | 91.85 | -0.04 | -0.04% |
VanEck Pharmaceutical ETF | |||
VSLU | 42.44 | -0.09 | -0.22% |
Applied Finance Valuation LgCp ETF | |||
TBX | 27.70 | -0.07 | -0.27% |
ProShares Short 7-10 Year Treasury | |||
MLPD | 24.93 | -0.16 | -0.65% |
Global X MLP & Engy Infras Cov Cll ETF | |||
MMLG | 35.83 | -0.32 | -0.89% |
First Trust Multi-Manager Large Gr ETF |